Thomas K Henthorn
Overview
Explore the profile of Thomas K Henthorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henthorn T, Wang G, Dooley G, Brooks-Russell A, Wrobel J, Limbacher S, et al.
Ther Drug Monit
. 2024 Sep;
46(5):672-680.
PMID: 39235358
Background: Unusually high variability in blood Δ9-tetrahydrocannabinol (THC) concentrations have been observed in subjects inhaling similar cannabis products over similar time periods when consumption is ad libitum. This makes simple...
2.
3.
Rzasa Lynn R, Henthorn T, Zuk J, Hammer G, Drover D, Levy R, et al.
Anesth Analg
. 2024 Jan;
138(2):447-455.
PMID: 38215717
Background: Fentanyl is widely used for analgesia and sedation in neonates, but pharmacokinetic (PK) analysis in this population has been limited by the relatively large sample volumes required for plasma-based...
4.
Okada C, Henthorn T, Zuk J, Sempio C, Roosevelt G, Ruiz A, et al.
Anesth Analg
. 2023 Oct;
138(1):99-107.
PMID: 37801572
Background: Childhood obesity is a significant problem. Obesity may alter the pharmacokinetics (PKs) of medications. Fentanyl is commonly used for procedural sedation, but there is a paucity of bolus dose...
5.
Kosnett M, Ma M, Dooley G, Wang G, Friedman K, Brown T, et al.
Clin Toxicol (Phila)
. 2023 Jun;
61(5):355-362.
PMID: 37293900
Introduction: Cannabis use is a growing concern in transportation and workplace incidents. Because Δ9-tetrahydrocannabinol is detectable after acute psychoactive effects have resolved, it has limitations as an indicator of recent...
6.
Rague J, Ma M, Dooley G, Wang G, Friedman K, Henthorn T, et al.
Clin Toxicol (Phila)
. 2023 Mar;
61(5):363-369.
PMID: 36939145
Introduction: The determination of recent cannabis use is of forensic interest in the investigation of automotive crashes, workplace incidents and other mishaps. Because Δ9-tetrahydrocannabinol may persist in blood after psychoactive...
7.
Crouch C, Wilkey B, Hendrickse A, Kaizer A, Schniedewind B, Christians U, et al.
Anesthesiology
. 2022 Dec;
138(1):71-81.
PMID: 36512707
Background: Postoperative pain associated with open partial hepatectomy can be intense and persistent. The multimodal approach used to lessen this problem includes an intraoperative intravenous infusion of lidocaine hydrochloride. Decreased...
8.
Dahan A, Olofsen E, Henthorn T, van Velzen M, Niesters M
Anesthesiology
. 2022 Sep;
137(6):748-749.
PMID: 36095056
No abstract available.
9.
Dahan A, Henthorn T
Front Pain Res (Lausanne)
. 2022 Sep;
3:991569.
PMID: 36081983
No abstract available.
10.
Sempio C, Huestis M, Kaplan B, Klawitter J, Christians U, Henthorn T
Drug Test Anal
. 2022 Mar;
14(8):1368-1376.
PMID: 35332698
Urine is a common matrix for screening for cannabis use. Urine assays typically measure total 11-nor-9-carboxy-Δ -tetrahydrocannabinol (THCCOOH) concentrations after hydrolysis cleaves the glucuronide. Urine THCCOOH concentration is adjusted by...